Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials

Documents similaires

• Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
  par: John Frewen, et autres
  Publié: (2024)
• Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
  par: Ogechi Ezemma, et autres
  Publié: (2024)
• Update on pulse corticosteroid therapy for the management of alopecia areata
  par: Jolina Bernhardt, et autres
  Publié: (2024)
• Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
  par: Ieva Lingytė, et autres
  Publié: (2024)
• Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
  par: Arash Mostaghimi, et autres
  Publié: (2024)